Maple Ridge Community Management Sponsors 9th Annual Summerfest Festival
MISSISSAUGA, Ontario, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Associa Maple Ridge Community Management (MRCM), a leading provider of condominium management...
Read moreDetails
Real Good Foods Highlights Another Record Dollar Sales Figure in the Most Recent SPINS Measured Channel Results
Real Good Foods Key Frozen Platforms Real Good Foods Key Frozen Platforms-- Breaded Chicken & Global Entrees CHERRY HILL, N.J.,...
Read moreDetailsRocky Mountain Chocolate Factory Schedules Fiscal Second Quarter 2024 Conference Call for October 12, 2023 at 8:30 A.M. ET
DURANGO, Colo., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, “Rocky Mountain...
Read moreDetailsRigetti Computing Awarded DARPA IMPAQT Contract to Advance Quantum Algorithms for Solving Combinatorial Optimization Problems
Rigetti was selected by the Defense Advanced Research Projects Agency (DARPA) to advance the state-of-the-art in quantum algorithms for solving...
Read moreDetailsMassachusetts Technology Leadership Council Welcomes Enrique Colbert, Mike DiTullio, Susan Hunt Stevens, and Gayatri Shenai to its Board of Trustees
LEXINGTON, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Massachusetts Technology Leadership Council (MTLC) is pleased to welcome four new Trustees...
Read moreDetailsDisc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers
WATERTOWN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
Read moreDetailsSight Sciences Announces New, Large-Scale MIGS Data from 41st Congress of ESCRS Demonstrating TCOR™ Using OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
Efficacy of the Three Most Commonly Used MIGS Technologies plus Cataract Surgery and Cataract Surgery Alone Were Evaluated and Compared...
Read moreDetailsKineta Announces Positive KVA12123 Monotherapy Safety and Biomarker Data from its Ongoing Phase 1/2 VISTA-101 Clinical Trial
Cleared First Three Monotherapy Cohorts with No Dose Limiting Toxicity and No Consistent Pattern of Adverse Events at any Dose...
Read moreDetailsSkyward Specialty and eMaxx Power Up Alternative Energy Warranty Products with an Expanded Captives Partnership
HOUSTON and PEABODY, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.™ (NASDAQ: SKWD) ("Skyward Specialty") a leader...
Read moreDetailsZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
BLOOMFIELD HILLS, Mich, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company...
Read moreDetailsADVERTISEMENTS
